Skip to Main Content

INFORMATION FOR

Piruz Motamedinia, MD

Associate Professor of Urology; Residency Program Director, Urology

Contact Information

Piruz Motamedinia, MD

Mailing Address

  • Urology

    Po Box 208058

    New Haven, CT 06520-8058

    United States

Research Summary

Dr. Motamedinia's research includes outcomes following kidney stone surgery, predictors of successful kidney stones surgery, and outcomes and risk factors for patients with upper tract urothelial cancer.

Coauthors

Research Interests

Urinary Bladder Neoplasms; Carcinoma, Transitional Cell; Kidney Calculi; Nephrostomy, Percutaneous; Obesity; Urology; Body Mass Index

Selected Publications

  • PD50-06 EXAMINING RISKS OF COMPOSITION CONVERSION IN RECURRENT STONE FORMERSNair H, Montgomery T, Siev M, Murphy E, Simmons K, Motamedinia P, Dahl N, Singh D. PD50-06 EXAMINING RISKS OF COMPOSITION CONVERSION IN RECURRENT STONE FORMERS Investigative Urology 2022, 207: e837. DOI: 10.1097/ju.0000000000002621.06.
  • MP20-08 UROLOGY RESIDENCY TRAINING IN MEDICALLY UNDERSERVED AREAS THROUGH THE INTEGRATION OF A FEDERALLY QUALIFIED HEALTH CENTER ROTATIONJavier-Desloges J, Segal D, Khan A, Abello A, Motamedinia P, Hittelman A, Rosoff J, Stroup R, Leapman M. MP20-08 UROLOGY RESIDENCY TRAINING IN MEDICALLY UNDERSERVED AREAS THROUGH THE INTEGRATION OF A FEDERALLY QUALIFIED HEALTH CENTER ROTATION Investigative Urology 2021, 206 DOI: 10.1097/ju.0000000000002005.08.
  • MP18-02 EVALUATING SPONTANEOUS STONE PASSAGE RATES DURING THE COVID-19 PANDEMICGhiraldi E, Hanchuk S, Buck M, Nair H, Singh D, Motamedinia P. MP18-02 EVALUATING SPONTANEOUS STONE PASSAGE RATES DURING THE COVID-19 PANDEMIC Investigative Urology 2021, 206 DOI: 10.1097/ju.0000000000002003.02.
  • MP22-05 DOES CT SCAN AFTER ULTRASOUND CHANGE SURGICAL PLANNING FOR NEPHROLITHIASIS?Ludvigson A, Motamedinia P. MP22-05 DOES CT SCAN AFTER ULTRASOUND CHANGE SURGICAL PLANNING FOR NEPHROLITHIASIS? Investigative Urology 2021, 206 DOI: 10.1097/ju.0000000000002013.05.
  • PD26-02 TORADOL (KETOROLAC) TO REDUCE URETEROSCOPY SYMPTOMS TRIALSyed J, Khan A, Goland-Van Ryn M, Motamedinia P. PD26-02 TORADOL (KETOROLAC) TO REDUCE URETEROSCOPY SYMPTOMS TRIAL Investigative Urology 2021, 206 DOI: 10.1097/ju.0000000000002019.02.
  • Analysis of Cost Variation in Endourological Procedures throughout the United States Using a National DatabaseAbello A, Goland-Van Ryn M, Kenney P, Singh D, Motamedinia P. Analysis of Cost Variation in Endourological Procedures throughout the United States Using a National Database Urology Practice 2020, 7: 174-181. DOI: 10.1097/upj.0000000000000080.
  • V04-03 TIPS AND TRICKS TO AVOID SUPRACOSTAL PERCUTANEOUS NEPHROLITHOTOMY ACCESSAro* T, Rai A, Hoenig D, Gupta M, Honey J, Motamedinia P, Smith A, Okeke Z. V04-03 TIPS AND TRICKS TO AVOID SUPRACOSTAL PERCUTANEOUS NEPHROLITHOTOMY ACCESS Investigative Urology 2020, 203: e387-e388. DOI: 10.1097/ju.0000000000000863.03.
  • MP34-18 ASSESSING BURNOUT AMONGST CONTEMPORARY UROLOGY TRAINEES: A MULTI-INSTITUTIONAL ANALYSISSmigelski* M, Korets R, MacLachlan L, Motamedinia P, Cooper K, Li G, Lee R, Badalato G. MP34-18 ASSESSING BURNOUT AMONGST CONTEMPORARY UROLOGY TRAINEES: A MULTI-INSTITUTIONAL ANALYSIS Investigative Urology 2020, 203 DOI: 10.1097/ju.0000000000000878.018.
  • FR02-04 UROLOGIC HEALTH THROUGHOUT THE HISTORY OF THE WHITE HOUSEAmirkhiz* K, Goland-Van Ryn M, Motamedinia P, Leapman M, Sprenkle P, Weiss R. FR02-04 UROLOGIC HEALTH THROUGHOUT THE HISTORY OF THE WHITE HOUSE Investigative Urology 2019, 201 DOI: 10.1097/01.ju.0000555417.67392.ee.
  • MP79-17 THE IMPACT OF INTRAOPERATIVE KETOROLAC ON OVERALL NARCOTIC REQUIREMENTS IN PATIENTS UNDERGOING URETEROSCOPY: A RANDOMIZED, CONTROLLED TRIALSyed J, Goland-Van Ryn* M, Huang J, Motamedinia P. MP79-17 THE IMPACT OF INTRAOPERATIVE KETOROLAC ON OVERALL NARCOTIC REQUIREMENTS IN PATIENTS UNDERGOING URETEROSCOPY: A RANDOMIZED, CONTROLLED TRIAL Investigative Urology 2019, 201 DOI: 10.1097/01.ju.0000557396.48819.c3.
  • Percutaneous Management of Upper Tract Urothelial CarcinomaPan S, Motamedinia P. Percutaneous Management of Upper Tract Urothelial Carcinoma 2018, 384-389. DOI: 10.1002/9781119245193.ch31.
  • [3] Incorporation of the fluoroless C-Arm Trainer at the American Urological Association hands-on training of percutaneous renal access: Pilot studyNoureldin Y, Hoening D, Zhao P, Elsamra S, Stern J, Gaunay G, Motamedinia P, Okeke Z, Rastinehad A, Sweet R. [3] Incorporation of the fluoroless C-Arm Trainer at the American Urological Association hands-on training of percutaneous renal access: Pilot study Arab Journal Of Urology 2018, 16: s3-s3. DOI: 10.1016/j.aju.2018.10.050.
  • P65 Incorporation of the fluoroless C-Arm Trainer at the American Urological Association hands on training percutaneous renal accessNoureldin Y, Hoenig D, Zhao P, Elsamra S, Stern J, Gaunay G, Motamedinia P, Okeke Z, Rastinehad A, Sweet R. P65 Incorporation of the fluoroless C-Arm Trainer at the American Urological Association hands on training percutaneous renal access European Urology Open Science 2018, 17: e2095. DOI: 10.1016/s1569-9056(18)32495-3.
  • MP44-16 VARIATION IN NATIONAL OPIOID PRESCRIBING PATTERNS FOLLOWING SURGERY FOR KIDNEY STONESLeapman M, DeRycke E, Skanderson M, Becker W, Makarov D, Gross C, Driscoll M, Motamedinia P, Bathulapalli H, Mattocks K, Brandt C, Haskell S, Bastian L. MP44-16 VARIATION IN NATIONAL OPIOID PRESCRIBING PATTERNS FOLLOWING SURGERY FOR KIDNEY STONES Investigative Urology 2018, 199: e594. DOI: 10.1016/j.juro.2018.02.1435.
  • MP50-13 NOVEL USE OF THE EPIC ELECTRONIC MEDICAL RECORD PLATFORM TO IDENTIFY LOST URETERAL STENTSJavier-Desloges J, Johnson K, Bryson C, Olszyk R, Kenney P, Motamedinia P. MP50-13 NOVEL USE OF THE EPIC ELECTRONIC MEDICAL RECORD PLATFORM TO IDENTIFY LOST URETERAL STENTS Investigative Urology 2018, 199: e680. DOI: 10.1016/j.juro.2018.02.1624.
  • PD35-04 PROSPECTIVE RANDOMIZED TRIAL OF ANTIBIOTIC PROPHYLAXIS DURATION FOR PERCUTANEOUS NEPHROLITHOTOMY: PRELIMINARY RESULTSSamson P, Derisavifard S, Morganstern B, Patel V, Leavitt D, Gaunay G, Motamedinia P, Elsamra S, Toor J, Smith A, Hoenig D, Okeke Z. PD35-04 PROSPECTIVE RANDOMIZED TRIAL OF ANTIBIOTIC PROPHYLAXIS DURATION FOR PERCUTANEOUS NEPHROLITHOTOMY: PRELIMINARY RESULTS Investigative Urology 2017, 197: e663-e664. DOI: 10.1016/j.juro.2017.02.1540.
  • Anatomic Variations of the UreterMotamedinia P, Leavitt D, Zhao P, Okeke Z, Smith A. Anatomic Variations of the Ureter 2017, 10-15. DOI: 10.1002/9781119085713.ch2.
  • Tandem Ureteral StentsLeavitt D, Motamedinia P, Zhao P, Okeke Z, Smith A. Tandem Ureteral Stents 2017, 175-181. DOI: 10.1002/9781119085713.ch18.
  • Etiology of Ureteric ObstructionZhao P, Leavitt D, Motamedinia P, Okeke Z, Smith A. Etiology of Ureteric Obstruction 2017, 48-54. DOI: 10.1002/9781119085713.ch5.
  • PD13-08 A 30-YEAR 250-CASE HISTORY OF PERCUTANEOUS ENDOSCOPIC RESECTION FOR UPPER TRACT UROTHELIAL CARCINOMA AT A SINGLE INSTITUTIONZhao P, Motamedinia P, Leavitt D, Keheila M, Hoenig D, Okeke Z, Smith A. PD13-08 A 30-YEAR 250-CASE HISTORY OF PERCUTANEOUS ENDOSCOPIC RESECTION FOR UPPER TRACT UROTHELIAL CARCINOMA AT A SINGLE INSTITUTION Investigative Urology 2016, 195: e300. DOI: 10.1016/j.juro.2016.02.979.
  • MP80-13 DOES THE PEAK INSPIRATORY PRESSURE INCREASE IN THE PRONE POSITION? AN ANALYSIS RELATED TO BMI.Siev M, Motamedinia P, Leavitt D, Hoenig D, Smith A, Okeke Z. MP80-13 DOES THE PEAK INSPIRATORY PRESSURE INCREASE IN THE PRONE POSITION? AN ANALYSIS RELATED TO BMI. Investigative Urology 2015, 193: e1024. DOI: 10.1016/j.juro.2015.02.2849.
  • MP38-05 THE MODERN ERA STRUVITE STONE: PATTERNS OF URINARY INFECTION AND COLONIZATIONDe Fazio A, Thummar H, Rothberg M, Motamedinia P, Badalato G, Gupta M. MP38-05 THE MODERN ERA STRUVITE STONE: PATTERNS OF URINARY INFECTION AND COLONIZATION Investigative Urology 2015, 193: e447. DOI: 10.1016/j.juro.2015.02.1380.
  • V8-07 EN BLOC BLADDER TUMOR RESECTION: BACK TO ONCOLOGIC BASICSMotamedinia P, Martov A, Okeke Z, Smith A. V8-07 EN BLOC BLADDER TUMOR RESECTION: BACK TO ONCOLOGIC BASICS Investigative Urology 2015, 193: e716-e717. DOI: 10.1016/j.juro.2015.02.2131.
  • MP30-08 CAN ACTIVITIES OF DAILY LIVING PREDICT FOR COMPLICATIONS FOLLOWING PERCUTANEOUS NEPHROLITHOTOMY?Leavitt D, Moran S, Motamedinia P, Siev M, Fakhoury M, Alom M, Hoenig D, Smith A, Okeke Z. MP30-08 CAN ACTIVITIES OF DAILY LIVING PREDICT FOR COMPLICATIONS FOLLOWING PERCUTANEOUS NEPHROLITHOTOMY? Investigative Urology 2015, 193: e350. DOI: 10.1016/j.juro.2015.02.590.
  • 1140 EVALUATION OF URINARY EXOSOMES IN BLADDER CANCER PATIENTSAhn J, Salazar G, Seaman M, Scott A, Motamedinia P, Castaneda C, Comper W, McKiernan J, Russo L. 1140 EVALUATION OF URINARY EXOSOMES IN BLADDER CANCER PATIENTS Investigative Urology 2013, 189: e465-e466. DOI: 10.1016/j.juro.2013.02.755.
  • 1328 URINARY EXOSOMAL RNA PROVIDES A NON-INVASIVE WAY TO ACCURATELY DETECT PCA3 EXPRESSION IN MEN UNDERGOING EVALUATION FOR PROSTATE CANCERShapiro E, Ahn J, Zampella B, Motamedinia P, Scott A, Salazar G, Bate K, Seaman M, Badani K, McKiernan J, Russo L. 1328 URINARY EXOSOMAL RNA PROVIDES A NON-INVASIVE WAY TO ACCURATELY DETECT PCA3 EXPRESSION IN MEN UNDERGOING EVALUATION FOR PROSTATE CANCER Investigative Urology 2013, 189: e542. DOI: 10.1016/j.juro.2013.02.2682.
  • 2052 THE NATURAL VARIATION OF PCA3 SCORES - IS ONE ENOUGH?Ahn J, Wenske S, Shapiro E, Mann M, Motamedinia P, Benson M, McKiernan J. 2052 THE NATURAL VARIATION OF PCA3 SCORES - IS ONE ENOUGH? Investigative Urology 2013, 189: e842. DOI: 10.1016/j.juro.2013.02.2471.
  • The impact of regional anesthesia on bladder cancer outcomes.RiChard J, Lipsky M, Whalen M, Motamedinia P, Finkelstein J, Hruby G, DeCastro G, Curry S, Benson M, McKiernan J. The impact of regional anesthesia on bladder cancer outcomes. Journal Of Clinical Oncology 2012, 30: e15021-e15021. DOI: 10.1200/jco.2012.30.15_suppl.e15021.
  • 2232 THE NOVEL USE OF URINARY EXOSOMES TO EXAMINE SURVIVIN EXPRESSION IN CASTRATION RESISTANT PROSTATE CANCERLin J, Scott A, Motamedinia P, Salazar G, Bate K, Lipsky M, Sadeghi N, Comper W, McKiernan J, Petrylak D, Russo L. 2232 THE NOVEL USE OF URINARY EXOSOMES TO EXAMINE SURVIVIN EXPRESSION IN CASTRATION RESISTANT PROSTATE CANCER Investigative Urology 2012, 187: e900. DOI: 10.1016/j.juro.2012.02.2408.
  • 711 THE IMPACT OF THE MINIMALLY INVASIVE CARE PATHWAY ON CONTEMPORARY OPEN PARTIAL NEPHRECTOMYFast A, Motamedinia P, Lipsky M, Hruby G, McKiernan J. 711 THE IMPACT OF THE MINIMALLY INVASIVE CARE PATHWAY ON CONTEMPORARY OPEN PARTIAL NEPHRECTOMY Investigative Urology 2012, 187: e291-e292. DOI: 10.1016/j.juro.2012.02.795.
  • 354 ROUTINE TRANSITION ZONE BIOPSY DURING ACTIVE SURVEILLANCE FOR PROSTATE CANCER RARELY PROVIDES UNIQUE EVIDENCE OF DISEASE PROGRESSIONRiChard J, Motamedinia P, DeCastro G, McKiernan J, Benson M. 354 ROUTINE TRANSITION ZONE BIOPSY DURING ACTIVE SURVEILLANCE FOR PROSTATE CANCER RARELY PROVIDES UNIQUE EVIDENCE OF DISEASE PROGRESSION Investigative Urology 2012, 187: e144. DOI: 10.1016/j.juro.2012.02.416.
  • 1135 IMPACT OF MINIMALLY INVASIVE SURGERY ON CONTEMPORARY OPEN PROSTATECTOMYMotamedinia P, Fast A, Benson M, McKiernan J. 1135 IMPACT OF MINIMALLY INVASIVE SURGERY ON CONTEMPORARY OPEN PROSTATECTOMY Investigative Urology 2012, 187: e460. DOI: 10.1016/j.juro.2012.02.1244.
  • 2203 NECESSITY OF CONFIRMATORY PROSTATE BIOPSY TO INSURE ACCURATE ELIGIBILITY FOR ACTIVE SURVEILLANCEMotamedinia P, RiChard J, Hruby G, DeCastro G, Benson M. 2203 NECESSITY OF CONFIRMATORY PROSTATE BIOPSY TO INSURE ACCURATE ELIGIBILITY FOR ACTIVE SURVEILLANCE Investigative Urology 2012, 187: e888. DOI: 10.1016/j.juro.2012.02.2378.
  • 2108 PREOPERATIVE URINARY EXOSOME DETECTION OF TMPRSS2:ERG MRNA CLOSELY CORRELATES WITH TISSUE EXPRESSION AT RADICAL PROSTATECTOMYMotamedinia P, Scott A, Bate K, Salazar G, Lipsky M, Sadeghi N, Comper W, McKiernan J, Russo L. 2108 PREOPERATIVE URINARY EXOSOME DETECTION OF TMPRSS2:ERG MRNA CLOSELY CORRELATES WITH TISSUE EXPRESSION AT RADICAL PROSTATECTOMY Investigative Urology 2012, 187: e850-e851. DOI: 10.1016/j.juro.2012.02.2276.
  • Urinary exosomes as a stable source of mRNA for prostate cancer analysis.Russo L, Bate K, Motamedinia P, Salazar G, Scott A, Lipsky M, Sadeghi N, Lin J, Comper W, Petrylak D, McKiernan J. Urinary exosomes as a stable source of mRNA for prostate cancer analysis. Journal Of Clinical Oncology 2012, 30: 174-174. DOI: 10.1200/jco.2012.30.5_suppl.174.
  • Abstract C133: The use of exosomal mRNA for noninvasive transcriptional analysis of the prostate.Russo L, Bate K, Motamedinia P, Sadeghi N, Salazar G, Scott A, Lipsky M, Lin J, Hruby G, Comper W, Petrylak D, McKiernan J. Abstract C133: The use of exosomal mRNA for noninvasive transcriptional analysis of the prostate. Molecular Cancer Therapeutics 2011, 10: c133-c133. DOI: 10.1158/1535-7163.targ-11-c133.
  • 1584 MINIMIZING RADIATION EXPOSURE DURING PERCUTANEOUS NEPHROLITHOTOMYMotamedinia P, Katsumi H, Gupta M. 1584 MINIMIZING RADIATION EXPOSURE DURING PERCUTANEOUS NEPHROLITHOTOMY Investigative Urology 2010, 183: e612. DOI: 10.1016/j.juro.2010.02.1350.
  • ACCURACY OF KATTAN NOMOGRAMS ACROSS PROSTATE CANCER RISK-GROUPSKorets R, Pierorazio P, Motamedinia P, Desai M, Benson M, McKiernan J. ACCURACY OF KATTAN NOMOGRAMS ACROSS PROSTATE CANCER RISK-GROUPS Investigative Urology 2009, 181: 759-760. DOI: 10.1016/s0022-5347(09)62116-9.
  • THE EFFECT OF ERYTHROPOIETIN ON ISCHEMIC DAMAGE IN THE CANINE KIDNEYPhillips C, Hruby G, Mirabile G, Motamedinia P, Lehman D, Sise M, Okhunov Z, Singh H, Schwartz M, Benson M, Barasch J, Cordon-Cardo C, Landman J. THE EFFECT OF ERYTHROPOIETIN ON ISCHEMIC DAMAGE IN THE CANINE KIDNEY Investigative Urology 2008, 179: 243. DOI: 10.1016/s0022-5347(08)60702-8.
  • 460: Increasing Body Mass Index is not an Independent Predictor of Outcome Following Radical ProstatectomyMotamedinia P, Korets R, Spencer B, Benson M, McKiernan J. 460: Increasing Body Mass Index is not an Independent Predictor of Outcome Following Radical Prostatectomy Investigative Urology 2007, 177: 154. DOI: 10.1016/s0022-5347(18)30713-4.